Back
Coherus Oncology, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
29
CHRS
Coherus Oncology, Inc.
Last Price:
$1.21
Seasonality Move:
0.05%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHRS is experiencing selling pressure, which indicates risk of future bearish movement.
Coherus Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.25 | Sell |
| 20-day SMA: | 1.24 | Sell |
| 50-day SMA: | 1.5 | Sell |
| 200-day SMA: | 1.11 | Buy |
| 8-day EMA: | 1.23 | Sell |
| 20-day EMA: | 1.29 | Sell |
| 50-day EMA: | 1.34 | Sell |
| 200-day EMA: | 0.83 | Buy |
Coherus Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 41.95 | Sell |
| Chaikin Money Flow: | -565791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.46) | Sell |
| Bollinger Bands (100): | (1.04 - 1.6) | Sell |
Coherus Oncology, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Coherus Oncology, Inc. Stock
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.20 while CHRS 8-day simple moving average is 1.25, which is a Sell signal.
-
The stock price of CHRS is 1.20 while Coherus Oncology, Inc. 20-day SMA is 1.24, which makes it a Sell.
-
Coherus Oncology, Inc. 50-day simple moving average is 1.50 while CHRS share price is 1.20, making it a Sell technically.
-
CHRS stock price is 1.20 and Coherus Oncology, Inc. 200-day simple moving average is 1.11, creating a Buy signal.
CHRS Technical Analysis vs Fundamental Analysis
Sell
29
Coherus Oncology, Inc. (CHRS)
is a Sell
Is Coherus Oncology, Inc. a Buy or a Sell?
-
Coherus Oncology, Inc. stock is rated a SellThe current Coherus Oncology, Inc. [CHRS] share price is $1.20. The Score for CHRS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Coherus Oncology, Inc. Stock Info
Market Cap:
145M
Price in USD:
1.20
Share Volume:
1M
Coherus Oncology, Inc. 52-Week Range
52-Week High:
1.89
52-Week Low:
0.71
Sell
29
Coherus Oncology, Inc. (CHRS)
is a Sell
Coherus Oncology, Inc. Share Price Forecast
-
What is the Coherus Oncology, Inc. stock price today?The Coherus Oncology, Inc. stock price is 1.20 USD today.
-
Will CHRS stock go up or go down?Coherus Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Coherus Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Coherus Oncology, Inc. is overvalued.
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.20 while CHRS 8-day exponential moving average is 1.23, which is a Sell signal.
-
The stock price of CHRS is 1.20 while Coherus Oncology, Inc. 20-day EMA is 1.29, which makes it a Sell.
-
Coherus Oncology, Inc. 50-day exponential moving average is 1.34 while CHRS share price is 1.20, making it a Sell technically.
-
CHRS stock price is 1.20 and Coherus Oncology, Inc. 200-day simple moving average is 0.83, creating a Buy signal.
Fundamental Analysis of Coherus Oncology, Inc.
Is Coherus Oncology, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and an increase next year of $0.84 per share.
Technical Analysis of Coherus Oncology, Inc.
Should I short Coherus Oncology, Inc. stock?
-
CHRS Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Coherus Oncology, Inc. is a Sell
-
Coherus Oncology, Inc. Relative Strength Index (RSI) is 41.95, which suggest Coherus Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Coherus Oncology, Inc. is (1.16 - 1.46), which suggest Coherus Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Coherus Oncology, Inc. is (1.04 - 1.6), which suggest Coherus Oncology, Inc. is a Sell
* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.